IPG Investment Advisors LLC Trims Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

IPG Investment Advisors LLC reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 51.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,741 shares of the biotechnology company's stock after selling 1,822 shares during the quarter. IPG Investment Advisors LLC's holdings in Axon Enterprise were worth $1,035,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Asset Dedication LLC boosted its position in Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after purchasing an additional 18 shares during the last quarter. Bleakley Financial Group LLC boosted its position in Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after purchasing an additional 20 shares during the period. Venturi Wealth Management LLC grew its stake in Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after buying an additional 21 shares during the last quarter. Insigneo Advisory Services LLC increased its stake in shares of Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after purchasing an additional 22 shares during the period. Finally, Menard Financial Group LLC increased its position in Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after buying an additional 24 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Insider Buying and Selling at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jeri Williams sold 307 shares of the firm's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 6.10% of the company's stock.

Axon Enterprise Stock Up 2.9 %

Axon Enterprise stock traded up $15.25 during midday trading on Tuesday, hitting $541.20. 508,898 shares of the stock were exchanged, compared to its average volume of 813,746. The business's 50-day moving average price is $588.26 and its 200-day moving average price is $551.61. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The stock has a market capitalization of $41.47 billion, a price-to-earnings ratio of 139.85, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on AXON shares. TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price objective for the company. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Barclays restated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. Finally, Morgan Stanley raised shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.